Finance

Beta
Lists
PDSB:NASDAQ
PDS Biotechnology Corp
၀.၈၄ US$
-၀.၉၆%
(-၀.၀၀၈၁) 1D
ဇူ ၇, GMT-၄ ၁၅:၃၃:၁၄  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PDSB...
Open
၀.၈၅ US$
High
၀.၈၆ US$
Low
၀.၈၀ US$
Mkt. cap
၄.၆၆ ကုဋေ
Avg. vol.
၈.၀၄ သိန်း
Volume
၁.၅၃ သိန်း
52-wk high
၁.၅၅ US$
52-wk low
၀.၅၁ US$
EPS
-၀.၆၈ US$
Beta
၁.၅၉
Shares outstanding
၅.၅၈ ကုဋေ
No. of employees
၂၁
Open
၀.၈၅ US$
High
၀.၈၆ US$
Low
၀.၈၀ US$
Mkt. cap
၄.၆၆ ကုဋေ
Avg. vol.
၈.၀၄ သိန်း
Volume
၁.၅၃ သိန်း
52-wk high
၁.၅၅ US$
52-wk low
၀.၅၁ US$
EPS
-၀.၆၈ US$
Beta
၁.၅၉
Shares outstanding
၅.၅၈ ကုဋေ
No. of employees
၂၁
News stories
From sources across the web
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၃ ပတ်
PDSB Q1 2026 Earnings: EPS Beat Fails to Lift Shares as Pipeline Progress Awaited - ROA Comparison
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၁ လ
PDS Biotechnology Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock Up 3.45% - Cash Flow Report
About PDS Biotechnology Corp
CEO-
Employees၂၁
Founded၂၀၀၅
Headquarters-
Sector-
Websitepdsbiotech.com
Analyst ratings
Based on 1 analyst giving stock ratings to PDSB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for PDSB in the last 3 months
Highest
Current ၀.၈၄ US$
၁၅.၀၀ US$ (+၁,၆၈၉.၉၈%)
Average
၁၅.၀၀ US$ (+၁,၆၈၉.၉၈%)
Lowest
၁၅.၀၀ US$ (+၁,၆၈၉.၉၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
၁၅.၀၀ US$
+၁,၆၉၀%
05/14/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
၃.၀၀ US$
+၂၅၈%
04/07/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
၄.၅၀ US$
+၄၃၇%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၄.၂၁ သန်း
၄.၅၈ သန်း
၄.၄၁ သန်း
၃.၄၆ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၄၁ သန်း
၃.၅၆ သန်း
၂.၂၇ သန်း
၃.၀၆ သန်း
Operating expense
၇.၆၂ သန်း
၈.၁၄ သန်း
၆.၆၇ သန်း
၆.၅၂ သန်း
Total operating expenses
၇.၆၂ သန်း
၈.၁၄ သန်း
၆.၆၇ သန်း
၆.၅၂ သန်း
Operating income
-၇.၆၂ သန်း
-၈.၁၄ သန်း
-၆.၆၇ သန်း
-၆.၅၂ သန်း
Other non operating income
-
-
-
-
EBT including unusual items
-၉.၄၃ သန်း
-၉.၀၁ သန်း
-၇.၅၆ သန်း
-၇.၃၅ သန်း
EBT excluding unusual items
-၉.၄၃ သန်း
-၉.၀၁ သန်း
-၇.၅၆ သန်း
-၇.၃၅ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၉.၄၃ သန်း
-၉.၀၁ သန်း
-၇.၅၆ သန်း
-၇.၃၅ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၀.၂၁
-၀.၁၉
-၀.၁၄
-၀.၁၃
Interest and investment income
၃.၃၄ သိန်း
၂.၈၁ သိန်း
၂.၂၅ သိန်း
၁.၈၇ သိန်း
Interest expense
-၂.၁၄ သန်း
-၁.၁၅ သန်း
-၁.၁၁ သန်း
-၁.၀၁ သန်း
Net interest expenses
-၁.၈၁ သန်း
-၈.၆၉ သိန်း
-၈.၈၈ သိန်း
-၈.၂၈ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၇.၆၁ သန်း
-၈.၁၃ သန်း
-၆.၆၆ သန်း
-၆.၅၁ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer